ScholarLens Back to search
2005•Prostate Cancer and Prostatic DiseasesRequires access

Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostate

C G Roehrborn

Open publisher page 46 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 46 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Alfuzosin, Medicine, Prostate, Urology, Placebo, Lower urinary tract symptoms, Hyperplasia, International Prostate Symptom Score

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostate — Research Paper | ScholarLens